Showing results (41-50 of 295) with videos related to

Sort By:
Pageof 30
Thoracic Cancer|March 7, 2022
Downregulation of PD-L1 and HLA-I in non-small cell lung cancer with ALK fusionDi Mu, Jingjing Guo, Wenwen Yu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 11, 2014
Pemetrexed-based chemotherapy in advanced lung adenocarcinoma patients with different EGFR genotypesXiangli Jiang, Bo Yang, Jiuqin Lu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 24, 2017
[Efficacy and Survival Analysis of Apatinib in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer after Failure of First-line Treatment]Xuemin Wang, Weihong Zhang, Weijiao Du, et al.
Cancer Biology & Therapy|July 15, 2009
IDO inhibits T-cell function through suppressing Vav1 expression and activationRunmei Li, Feng Wei, Jinpu Yu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 17, 2017
Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doubletYanjuan Xiong, Ning Zhao, Yu Zheng, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 2, 2015
Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatmentWei Pan, Qian Sun, Yang Wang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 11, 2012
Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancerYing Chen, Lei Zhang, Jing Tian, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 25, 2024
Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapyYanan Cui, Yanping Chen, Peiyan Zhao, et al.
Pageof 30